Terje Pedersen

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

Ian D. Graham, Dan Atar, K. Borch‐Johnsen et al. · European Heart Journal · 2007 · 3.8K citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Željko Reiner, Alberico L. Catapano, Guy De Backer et al. · European Heart Journal · 2011 · 3.5K citations · Full text

Medicine, Cardiology, Internal Medicine +17

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Colin Baigent, Martin Landray, Christina Reith et al. · The Lancet · 2011 · 2.5K citations

Pharmacy, Cardiology, Pharmacotherapy +16

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

Lixin Jiang, Jemma C. Hopewell, Jing Li et al. · European Heart Journal · 2013 · 673 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +8

Cholesterol-Lowering Therapy in Women and Elderly Patients With Myocardial Infarction or Angina Pectoris

Tatu A. Miettinen, Kalevi Pyörälà, Anders Olsson et al. · Circulation · 1997 · 509 citations

Pharmacy, Cardiology, Pharmacotherapy +17